Rheumatoid Arthritis

72 competing products in clinical development for Rheumatoid Arthritis.

Pipeline by Phase

Pre-clinical11

Phase 112

Phase 1/22

Phase 27

Phase 2/31

Phase 331

Approved8

All Products (72)

Product	Company	Stage	Status	Hype
Filgotinib Maleate	Eisai	Approved	Active	47
Baricitinib + TNF Inhibitor	Eli Lilly	Approved	Completed	43
Tacrolimus	Astellas Pharma	Approved	Completed	43
tacrolimus + placebo	Astellas Pharma	Approved	Completed	43
Tacrolimus	Astellas Pharma	Approved	Completed	43
Tacrolimus	Astellas Pharma	Approved	Completed	43
Methotrexate + Adalimumab	Eisai	Approved	Completed	43
Abatacept + Placebo matching with Abatacept + Methotrexate	Ono Pharmaceutical	Approved	Completed	43
Baricitinib + Methotrexate + Baricitinib Placebo + MTX Placebo + Folic Acid	Eli Lilly	Phase 3	Completed	40
CT-P17 SC AI (adalimumab)	Celltrion	Phase 3	Completed	40
CT-P13 + Remicade	Celltrion	Phase 3	Completed	40
CT-P47 + EU-approved RoActemra	Celltrion	Phase 3	Completed	40
Infliximab	Celltrion	Phase 3	Completed	40
CT-P10 + Rituxan + MabThera	Celltrion	Phase 3	Completed	40
CT-P13 + CT-P13 + CT-P13 + CT-P13 + CT-P13 + CT-P13	Celltrion	Phase 3	Completed	40
CT-P17 SC + Humira SC	Celltrion	Phase 3	Completed	40
Infliximab	Celltrion	Phase 3	Completed	40
MRA(Tocilizumab) + MRA placebo + MTX + MTX placebo	Chugai Pharmaceutical	Phase 3	Completed	40
MRA(Tocilizumab)	Chugai Pharmaceutical	Phase 3	Completed	40
MRA(Tocilizumab)	Chugai Pharmaceutical	Phase 3	Completed	40
MRA(Tocilizumab)	Chugai Pharmaceutical	Phase 3	Completed	40
MRA (Tocilizumab)	Chugai Pharmaceutical	Phase 3	Completed	40
MRA (Tocilizumab)	Chugai Pharmaceutical	Phase 3	Completed	40
CHS-0214	Daiichi Sankyo	Phase 3	Completed	40
Etanercept + CHS-0214	Daiichi Sankyo	Phase 3	Completed	40
Peficitinib + Placebo + Etanercept	Astellas Pharma	Phase 3	Completed	40
Certolizumab pegol	Astellas Pharma	Phase 3	Completed	40
Peficitinib + Placebo + Methotrexate	Astellas Pharma	Phase 3	Completed	40
Tacrolimus (Prograf®) + Methotrexate	Astellas Pharma	Phase 3	Completed	40
Certolizumab pegol + Methotrexate	Astellas Pharma	Phase 3	Completed	40
Placebo + CZP + methotrexate (MTX)	Astellas Pharma	Phase 3	Completed	40
Double-blind adalimumab + Double-blind Placebo + Open-label Adalimumab + Open-labelAdalimumabRescue	Eisai	Phase 3	Completed	40
adalimumab + methotrexate	Eisai	Phase 3	Completed	40
T-614 + Placebo	Eisai	Phase 3	Completed	40
adalimumab	Eisai	Phase 3	Completed	40
Adalimumab	Eisai	Phase 3	Completed	40
adalimumab + adalimumab + adalimumab + placebo	Eisai	Phase 2/3	Completed	38
Experimental: Arm A: DRL_RI + Arm B: Rituxan®/Mabthera®	Dr. Reddy's Laboratories	Phase 3	Completed	37
CT-P47 AI (tocilizumab) + CT-P47 PFS (tocilizumab)	Celltrion	Phase 3	UNKNOWN	36
MRA(Tocilizumab)	Chugai Pharmaceutical	Phase 2	Completed	35
ASP1707 + Placebo + Methotrexate	Astellas Pharma	Phase 2	Completed	35
E6011 + Placebo	Eisai	Phase 2	Completed	35
adalimumab	Eisai	Phase 2	Completed	35
E6011 + Placebo	Eisai	Phase 2	Completed	35
Remsima IV + Remsima SC	Celltrion	Pre-clinical	Recruiting	33
LY2127399	Eli Lilly	Phase 3	Terminated	32
ASK8007 + Placebo	Astellas Pharma	Phase 1/2	Completed	32
DRL_RI + Rituxan + MabThera	Dr. Reddy's Laboratories	Phase 1/2	Completed	29
Rituximab, MTX, folic acid	Celltrion	Phase 1	Completed	29
rituximab	Celltrion	Phase 1	Completed	29
AMP-110	Daiichi Sankyo	Phase 1	Completed	29
AMP-110	Daiichi Sankyo	Phase 1	Completed	29
AC430	Daiichi Sankyo	Phase 1	Completed	29
ASP2408 + Placebo	Astellas Pharma	Phase 1	Completed	29
peficitinib + methotrexate	Astellas Pharma	Phase 1	Completed	29
ASP2409 + Placebo	Astellas Pharma	Phase 1	Completed	29
ASP1707 + methotrexate (MTX)	Astellas Pharma	Phase 1	Completed	29
Tirabrutinib + Placebo	Ono Pharmaceutical	Phase 1	Completed	29
placebo + methotrexate + ocrelizumabu 50mg + ocrelizumabu 200mg + ocrelizumab 500mg	Chugai Pharmaceutical	Phase 2	Terminated	27
Tocilizumab Prefilled Syringe	Dr. Reddy's Laboratories	Phase 1	Completed	26
MRA(Tocilizumab)	Chugai Pharmaceutical	Pre-clinical	Completed	26
MRA(Tocilizumab)	Chugai Pharmaceutical	Pre-clinical	Completed	26
denosumab + placebo	Daiichi Sankyo	Pre-clinical	Completed	26
tacrolimus + biological agents	Astellas Pharma	Pre-clinical	Completed	26
abatacept	Astellas Pharma	Pre-clinical	Completed	26
Iguratimod	Eisai	Pre-clinical	Completed	26
Orencia	Ono Pharmaceutical	Pre-clinical	Completed	26
Orencia	Ono Pharmaceutical	Pre-clinical	Completed	26
ORENCIA Subcutaneous Injection	Ono Pharmaceutical	Pre-clinical	Completed	26
Tc99m tilmanocept	Navidea Biopharmaceuticals	Phase 2	Completed	25
Test Product + Reference product + Reference Medicinal Product	Dr. Reddy's Laboratories	Phase 1	UNKNOWN	22
Adalimumab	Celltrion	Pre-clinical	UNKNOWN	22